Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 13 Issue: 8, October 2013

In Memory of Dr. Herbert E. Nieburgs – Ex-Associate Editor of CCDT

Volume:13   Issue: 8
Pp: 811-813

DOI: 10.2174/1568009611313080001
Published on: 03 October, 2013

Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action

Volume:13   Issue: 8
Pp: 814-828
Sofia A. Santos and Alexandra Paulo
DOI: 10.2174/15680096113139990082
Published on: 03 October, 2013

Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia

Volume:13   Issue: 8
Pp: 829-842
Naoki Mori, Chie Ishikawa, Jun-Nosuke Uchihara and Takeshi Yasumoto
DOI: 10.2174/156800961131300093
Published on: 05 September, 2013

Signal Transduction in Human Cutaneous Melanoma and Target Drugs open access plus

Volume:13   Issue: 8
Pp: 843-866
Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov
DOI: 10.2174/1568009611313080004
Published on: 03 October, 2013

β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid open access plus

Volume:13   Issue: 8
Pp: 867-878
Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga
DOI: 10.2174/15680096113139990081
Published on: 03 October, 2013

Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma

Volume:13   Issue: 8
Pp: 879-894
Ana Burgeiro, Faustino Mollinedo and Paulo J. Oliveira
DOI: 10.2174/15680096113139990080
Published on: 03 October, 2013

Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

Volume:13   Issue: 8
Pp: 895-904
Caroline Hinton, Helma Antony, Saeed M. Hashimi, Alan Munn and Ming Q. Wei
DOI: 10.2174/156800961131300092
Published on: 05 September, 2013